Mary Mosher

Array ( [id] => 6134300 [patent_doc_number] => 20110008256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'MONOCLONAL ANTIBODIES THAT BIND OR NEUTRALIZE DENGUE VIRUS' [patent_app_type] => utility [patent_app_number] => 12/607035 [patent_app_country] => US [patent_app_date] => 2009-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 39406 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008256.pdf [firstpage_image] =>[orig_patent_app_number] => 12607035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6046821 [patent_doc_number] => 20110206718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'ANTI-FMD VACCINE COMPOSITION AND PREPARATION AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/125907 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12122 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20110206718.pdf [firstpage_image] =>[orig_patent_app_number] => 13125907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8151714 [patent_doc_number] => 08168200 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-01 [patent_title] => 'Vaccine against african horse sickness virus' [patent_app_type] => utility [patent_app_number] => 12/604048 [patent_app_country] => US [patent_app_date] => 2009-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 51 [patent_no_of_words] => 25718 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168200.pdf [firstpage_image] =>[orig_patent_app_number] => 12604048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8189273 [patent_doc_number] => 08183220 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Double-effective vaccine vector against foot-and-mouth disease virus (FMDV), methods of preparing and using the same' [patent_app_type] => utility [patent_app_number] => 12/577900 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 11 [patent_no_of_words] => 5099 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/183/08183220.pdf [firstpage_image] =>[orig_patent_app_number] => 12577900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273119 [patent_doc_number] => 08637046 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Bovine herpes virus-1 compositions, vaccines and methods' [patent_app_type] => utility [patent_app_number] => 13/121566 [patent_app_country] => US [patent_app_date] => 2009-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 17380 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13121566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8834533 [patent_doc_number] => 08450289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'Compositions comprising a parvovirus VP1-variant and a parvovirus NS1 protein for induction of cytolysis' [patent_app_type] => utility [patent_app_number] => 12/570913 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 4564 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12570913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4634042 [patent_doc_number] => 08012490 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-06 [patent_title] => 'Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents' [patent_app_type] => utility [patent_app_number] => 12/564702 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7664 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/012/08012490.pdf [firstpage_image] =>[orig_patent_app_number] => 12564702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6254287 [patent_doc_number] => 20100028860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Porcine Reproductive and Respiratory Syndrome Isolates and Methods of Use' [patent_app_type] => utility [patent_app_number] => 12/548597 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9829 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028860.pdf [firstpage_image] =>[orig_patent_app_number] => 12548597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8213880 [patent_doc_number] => 08192975 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith' [patent_app_type] => utility [patent_app_number] => 12/583679 [patent_app_country] => US [patent_app_date] => 2009-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8937 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/192/08192975.pdf [firstpage_image] =>[orig_patent_app_number] => 12583679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6411813 [patent_doc_number] => 20100166705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Culturing circular ssDNA viruses for the production of vaccines' [patent_app_type] => utility [patent_app_number] => 12/510844 [patent_app_country] => US [patent_app_date] => 2009-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13697 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166705.pdf [firstpage_image] =>[orig_patent_app_number] => 12510844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5551915 [patent_doc_number] => 20090285901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'Polyamino acid for use as adjuvant' [patent_app_type] => utility [patent_app_number] => 12/458895 [patent_app_country] => US [patent_app_date] => 2009-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10093 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285901.pdf [firstpage_image] =>[orig_patent_app_number] => 12458895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6440089 [patent_doc_number] => 20100279385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'PURIFICATION OF ADENOVIRUS AND AAV' [patent_app_type] => utility [patent_app_number] => 12/504073 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12346 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279385.pdf [firstpage_image] =>[orig_patent_app_number] => 12504073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6550955 [patent_doc_number] => 20100233206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'Marek\'s Disease Virus Vaccine Compositions and Methods of Using Thereof' [patent_app_type] => utility [patent_app_number] => 12/502822 [patent_app_country] => US [patent_app_date] => 2009-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 15616 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20100233206.pdf [firstpage_image] =>[orig_patent_app_number] => 12502822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7686084 [patent_doc_number] => 20100120057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'METHODS OF REDUCING NON-SPECIFIC INTERACTION IN METAL NANOPARTICLE ASSAYS' [patent_app_type] => utility [patent_app_number] => 12/500549 [patent_app_country] => US [patent_app_date] => 2009-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4765 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120057.pdf [firstpage_image] =>[orig_patent_app_number] => 12500549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6529286 [patent_doc_number] => 20100015180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Stabilizer and Vaccine Composition Comprising One or More Live Attenuated Flaviviruses' [patent_app_type] => utility [patent_app_number] => 12/500156 [patent_app_country] => US [patent_app_date] => 2009-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6510 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015180.pdf [firstpage_image] =>[orig_patent_app_number] => 12500156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8082361 [patent_doc_number] => 08148497 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-03 [patent_title] => 'Binding molecules capable of neutralizing rabies virus and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/459661 [patent_app_country] => US [patent_app_date] => 2009-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 36147 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/148/08148497.pdf [firstpage_image] =>[orig_patent_app_number] => 12459661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6601604 [patent_doc_number] => 20100098726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'VIRUS-EXPRESSING HOST COSTIMULATION MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/497597 [patent_app_country] => US [patent_app_date] => 2009-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7476 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20100098726.pdf [firstpage_image] =>[orig_patent_app_number] => 12497597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054527 [patent_doc_number] => 20110110887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'RECOMBINANT HERPESVIRUS OF TURKEYS ENCODING FOR INTERLEUKIN-12' [patent_app_type] => utility [patent_app_number] => 13/000753 [patent_app_country] => US [patent_app_date] => 2009-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3690 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110887.pdf [firstpage_image] =>[orig_patent_app_number] => 13000753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8409946 [patent_doc_number] => 08273342 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-25 [patent_title] => 'Anti-virus therapy for respiratory diseases' [patent_app_type] => utility [patent_app_number] => 12/487563 [patent_app_country] => US [patent_app_date] => 2009-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 49 [patent_no_of_words] => 28113 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12487563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4493745 [patent_doc_number] => 07947281 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'Chimeric proteins that induce effects directed against viruses' [patent_app_type] => utility [patent_app_number] => 12/483607 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20800 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947281.pdf [firstpage_image] =>[orig_patent_app_number] => 12483607 [rel_patent_id] =>[rel_patent_doc_number] =>)